New drug combo aims to fight tough breast cancer
NCT ID NCT07045311
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests two different drug combinations—JS207 plus 9MW2821 or JS207 plus albumin paclitaxel—as a first treatment for people with recurrent or metastatic triple-negative breast cancer. The study will enroll 80 participants to see if these combinations can shrink tumors and control the disease. Researchers will also monitor side effects and how long the benefits last.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
JS207 combined with 9MW2821 or albumin paclitaxel
What this could lead to
If successful, this could offer a new first-line treatment option for people with advanced triple-negative breast cancer, potentially improving tumor shrinkage and delaying disease progression.
What could go wrong
This is an early Phase 2 trial with only 80 participants, so results may not apply to everyone. The combination therapies may cause side effects, and there is no guarantee they will work better than existing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Hebei University
RECRUITINGBaoding, Hebei, 071030, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Affiliated Tumor Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang Uygur Autonomous Region, 830000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Anhui Provincial Cancer Hospital
NOT_YET_RECRUITINGHefei, Anhui, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ceneral Hosipital of Ningxia Medical University
NOT_YET_RECRUITINGYinchuan, Ningxia, 750000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Guangdong women and children's hospital and health institute
NOT_YET_RECRUITINGGuangzhou, Guangdong, 511400, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Harbin Medical University Affiliated Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150001, China
-
Harbin Medical University Affiliated Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Henan Cancer Hospital
RECRUITINGZhangzhou, Henan, 450003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430079, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jiangsu Province Hospital
NOT_YET_RECRUITINGNanjing, Jiangsu, 210029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jilin University First Hospital
RECRUITINGChangchun, Jilin, 130021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Liaoning Cancer Hospital&Institute
RECRUITINGShenyang, Liaoning, 110801, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nanchang People'S Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, 330000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Contact
-
The Affiliated Hospital of Qingdao University
RECRUITINGQingdao, Shandong, 266035, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Fifth Medical Center of PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, 100071, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXian, Shanxi, 710061, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Second Affiliated Hospital Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Second Hospital of Dalian Medical University
RECRUITINGDalian, Liaoning, 116027, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Xi'an International Medical Center Hospital
RECRUITINGXian, Shanxi, 710100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact